Black Diamond Therapeutics, Inc. (BDTX)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation

Ask a question about Black Diamond Therapeutics, Inc. (BDTX)

Company Performance

Current Price

as of Dec 06, 2024

$2.41

P/E Ratio

N/A

Market Cap

$136.37M

Description

Black Diamond Therapeutics, Inc. is a precision oncology medicine company, which engages in discovery and development of small molecule, masterkey therapies. The company was founded by David M. Epstein and Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.

Metrics

Overview

HQCambridge, MA
SectorHealth Technology
IndustryBiotechnology
TickerBDTX
Price$2.41+2.55%

Trading Information

Market cap$136.37M
Float75.80%
Average Daily Volume (1m)465,603
Average Daily Volume (3m)1,178,716
EPS-$1.36

Company

RevenueN/A
Rev growth (1yr)N/A
Net income-$15.56M
Gross marginN/A
EBITDA marginN/A
EBITDA-$18.04M

EV$156.13M
EV/RevenueN/A
P/EN/A
P/SN/A
P/B1.40

Ask a question about Black Diamond Therapeutics, Inc. (BDTX)

Company Performance

Description

Metrics

Documents